Thermo Fisher Scientific and Applikon Biotechnology Sign Bilateral Supply Agreement

  • Email
  • Print

Integrated Advanced Applikon control systems with Thermo Scientific HyClone Single-Use Bioreactors

Schiedam, the Netherlands (June XX , 2012) ­ Applikon Biotechnology, a global leading supplier of bioreactor control systems to the biopharma market, today announced the signing of a bilateral supply agreement with Thermo Fisher Scientific Inc., the world leader in serving science. As part of the agreement, Thermo Fisher and Applikon have developed an integrated solution that combines the Thermo Scientific HyClone™ Single-Use Bioreactor (S.U.B.) with the industry leading Applikon ez- and i-Control systems. Thermo Scientific will resell this solution under the Thermo Scientific HyPerforma™ product suite. Applikon will resell the S.U.B. as a integrated solution. With more than 200 joint customers, the Applikon control systems are well accepted in the market and offer clear advantages in reliability and ease of operation.

“CMC Biologics has been utilizing Thermo Fisher Scientific’s S.U.B.s in sizes ranging from 50 L through 2000 L, which are integrated with the Applikon ez-Control systems. We are extremely pleased with the seamless integration and ease of use,” said Gustavo Mahler, chief operations officer for CMC Biologics. “As a global CMO that is expanding its manufacturing capacity, we depend on reliable solutions to serve our customers with excellence, and achieve this through strong partnerships like these.”

“Applikon and Thermo Fisher have a shared vision for the promise of single-use bioreactor systems and we are excited to partner with them to integrate Thermo Scientific HyClone Single-Use Bioreactors with our advanced bioreactor control systems,” said Erik Kakes, commercial director of Applikon Biotechnology. Applikon has a strong portfolio of measurement and control instrumentation and is well recognized worldwide for its bioreactor systems.

“Thermo Fisher Scientific and Applikon Biotechnology have a long history of successful collaboration,” said Millie Ullah, senior product manager for single-use technology for Thermo Scientific cell culture and bioprocessing products. “The supply agreement deepens our partnership and provides our customers with assurance that both companies are committed to supporting their needs.”

To learn more about Applikon Biotechnology and their bioprocess solutions, visit

About Applikon Biotechnology B.V.

Applikon Biotechnology BV (Schiedam, Netherlands) is a privately owned leading supplier of bioreactor systems for the pharmaceutical and the biotechnological market. We specialize in novel technologies in cultivation systems, measurement and control for the biopharmaceu­ti­cal industry. In the past years, Applikon Biotechnology has built up a broad portfolio of unique bioprocessing devices for both cell culture and microbial cultivation, and this has considerably set us apart from the competition. We are definitely a step ahead.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $12 billion, we have approximately 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity™ Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Visit

  • <<
  • >>